BANGALORE: Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 25mg, 50mg, 100mg and 200mg extended-release tablets of Metoprolol succinate, a cardiac drug.